keyword
middl
east
respiratori
syndrom
coronaviru
merscov
epidemiolog
diagnosi
treatment
middl
east
respiratori
syndrom
mer
novel
lethal
zoonot
diseas
human
endem
middl
east
caus
mer
coronaviru
merscov
human
thought
acquir
merscov
though
contact
camel
camel
product
mer
carri
mortal
rate
specif
treatment
mer
persontoperson
spread
caus
hospit
household
outbreak
merscov
million
visitor
travel
saudi
arabia
year
across
world
thu
watch
surveil
high
degre
clinic
awar
earli
diagnosi
rapid
implement
infect
control
measur
return
travel
import
infect
di
clin
n
middl
east
respiratori
syndrom
coronaviru
merscov
new
zoonot
human
viral
pathogen
endem
middl
east
identifi
lung
sampl
patient
die
respiratori
failur
jeddah
saudi
arabia
diseas
caus
merscov
name
middl
east
respiratori
syndrom
mer
mer
remain
radar
global
public
health
author
recurr
nosocomi
commun
outbreak
associ
sever
diseas
high
mortal
rate
intermitt
sporad
case
commun
cluster
nosocomi
outbreak
merscov
continu
occur
saudi
arabia
merscov
remain
world
health
organ
blueprint
list
prioriti
pathogen
remain
persist
threat
global
health
secur
case
mer
outsid
middl
east
report
contin
link
travel
middl
east
nosocomi
outbreak
merscov
infect
account
approxim
merscov
case
global
larg
health
careassoci
outbreak
merscov
occur
saudi
arabia
unit
arab
emir
republ
korea
june
juli
merscov
caus
largest
outbreak
outsid
arabian
peninsula
republ
korea
result
confirm
mer
case
death
occur
korean
travel
return
trip
qatar
unit
arab
emir
uae
saudi
arabia
bahrain
becam
ill
respiratori
ill
visit
sever
hospit
final
diagnos
merscov
infect
may
samsung
medic
center
result
peopl
includ
health
care
worker
hcw
contract
merscov
infect
case
associ
hospit
transmiss
outbreak
clearli
illustr
epidem
potenti
merscov
spread
persontoperson
number
merscov
case
report
steadili
increas
sinc
first
report
merscov
septemb
merscov
case
continu
report
commun
hospit
across
arabian
peninsula
juli
case
laboratoryconfirm
mer
case
report
death
mortal
fig
approxim
human
case
report
saudi
arabia
twentyseven
countri
report
case
mer
exact
mode
transmiss
merscov
human
yet
accur
defin
epidemiolog
genet
phenotyp
studi
indic
dromedari
camel
appear
main
intermediari
reservoir
merscov
camel
assum
intermediari
host
speci
merscov
although
exact
sourc
mode
transmiss
mani
primari
mer
case
remain
unclear
antibodi
merscov
detect
serum
milk
collect
camel
qatar
april
one
studi
activ
viru
shed
nasal
secret
fece
observ
camel
merscov
surviv
prolong
period
camel
milk
viabl
viru
becam
undetect
pasteur
c
minut
merscov
detect
camel
kenya
camel
studi
enzymelink
immunosorb
assay
elisa
seroposit
camel
nasal
swab
posit
merscov
quantit
reversetranscript
polymeras
chain
reaction
rtpcr
studi
human
kenya
detect
merscov
neutral
antibodi
person
live
rural
area
although
human
mer
case
detect
yet
primari
sourc
human
merscov
infect
remain
unknown
definit
data
epidemiolog
link
human
merscov
infect
bat
one
fragment
merscov
close
match
human
isol
merscov
found
studi
sampl
taphoz
bat
phylogenet
analysi
mersrel
cov
identifi
neoromicia
capensi
bat
sampl
south
africa
support
hypothesi
bat
evolutionari
sourc
merscov
zoonot
reservoir
date
sustain
humantohuman
transmiss
document
although
tertiari
quaternari
spread
occur
korean
outbreak
risk
factor
primari
middl
east
respiratori
syndrom
coronaviru
infect
sever
independ
risk
factor
increas
suscept
acquir
primari
merscov
infect
identifi
direct
dromedari
exposur
fortnight
ill
onset
direct
physic
contact
dromedari
camel
previou
month
diabet
mellitu
heart
diseas
risk
factor
merscov
infect
among
camel
worker
includ
milk
camel
contact
camel
wast
poor
hand
hygien
anim
task
train
activ
worker
respiratori
symptom
requir
overnight
stay
hospit
viral
rna
sequenc
confirm
camel
human
transmiss
merscov
known
exposur
infect
camel
recent
data
suggest
although
merscov
widespread
among
dromedari
camel
middl
east
africa
zoonot
transmiss
merscov
camel
human
rel
uncommon
human
diseas
directli
proport
potenti
exposur
merscov
transmit
easili
persontoperson
unless
close
contact
occur
provid
care
patient
household
nosocomi
set
diagnosi
merscov
yet
recogn
laps
institut
infect
control
measur
symptom
sign
laboratori
imag
abnorm
associ
merscov
infect
mersspecif
like
respiratori
tract
infect
rti
box
tabl
clinic
manifest
merscov
infect
rang
asymptomat
infect
mild
moder
sever
diseas
often
complic
sever
pneumonia
acut
respiratori
distress
syndrom
ard
septic
shock
multiorgan
failur
incub
period
day
mild
case
lowgrad
fever
chill
runni
nose
dri
cough
sore
throat
myalgia
patient
gastrointestin
symptom
nausea
vomit
diarrhea
fever
may
absent
hospit
case
laboratori
abnorm
includ
cytopenia
elev
transaminas
see
tabl
coinfect
respiratori
virus
bacteri
pathogen
report
half
mer
case
acut
kidney
injuri
onethird
ill
patient
gastrointestin
symptom
sever
ill
caus
respiratori
failur
requir
mechan
ventil
support
intens
care
unit
icu
rapid
progress
ard
multisystem
diseas
organ
failur
median
day
hospit
icu
admiss
merscov
infect
appear
caus
sever
diseas
older
peopl
peopl
weaken
immun
system
chronic
diseas
renal
diseas
cancer
chronic
lung
diseas
diabet
case
studi
patient
mer
saudi
arabia
seen
decemb
novemb
found
overal
mortal
patient
older
like
die
mortal
infect
younger
patient
patient
preexist
medic
comorbid
tend
sever
diseas
higher
mortal
rate
factor
associ
poor
manag
outcom
sever
diseas
death
patient
mer
includ
old
age
male
gender
comorbid
preexist
ill
obes
diabet
mellitu
heart
lung
diseas
immunocompromis
state
low
serum
albumin
concomit
infect
posit
plasma
merscov
rna
receptor
shown
upregul
lung
smoker
may
explain
patient
comorbid
lung
diseas
prone
sever
ill
mani
case
merscov
easili
miss
present
communityacquir
pneumonia
respiratori
ill
caus
influenza
b
respiratori
syncyti
viru
parainfluenza
virus
rhinovirus
adenovirus
enterovirus
eg
human
metapneumoviru
endem
human
coronavirus
ie
nosocomi
outbreak
merscov
associ
delay
diagnosi
histori
travel
middl
east
import
patient
present
nonmiddl
eastern
countri
febril
ill
middl
east
respiratori
syndrom
sputum
endotrach
aspir
bronchoalveolar
lavag
collect
merscov
test
possibl
patient
sign
symptom
lower
respiratori
tract
diseas
collect
lower
tract
specimen
possibl
clinic
indic
upper
respiratori
tract
specimen
nasopharyng
aspir
combin
nasopharyng
oropharyng
swab
collect
take
nasopharyng
oropharyng
specimen
dacron
rayon
swab
specif
design
collect
specimen
virolog
must
use
swab
kit
contain
viru
transport
medium
nasopharyng
oropharyng
swab
place
tube
increas
viral
load
singl
neg
test
result
exclud
diagnosi
repeat
sampl
test
strongli
recommend
confirm
clearanc
viru
respiratori
sampl
collect
sequenti
everi
day
ensu
day
consecut
neg
result
clinic
recov
person
specimen
merscov
detect
reach
laboratori
soon
possibl
collect
deliv
promptli
laboratori
ship
c
possibl
like
delay
hour
specimen
reach
laboratori
recommend
specimen
frozen
c
ideal
c
ship
dri
ice
import
avoid
repeat
freez
thaw
specimen
laboratori
test
middl
east
respiratori
syndrom
coronaviru
accur
laboratori
molecular
diagnost
test
avail
use
highli
sensit
specif
realtim
rtpcr
rrtpcr
three
rrtpcr
assay
routin
detect
merscov
develop
target
upstream
e
protein
gene
upe
open
read
frame
orf
orf
assay
upe
target
consid
highli
sensit
recommend
screen
orf
assay
consid
equal
sensit
date
rrtpcr
assay
shown
crossreact
respiratori
virus
includ
human
coronavirus
suitabl
detect
known
merscov
strain
human
dromedari
camel
laboratori
confirm
merscov
infect
obtain
detect
viru
merscovspecif
nucleic
acid
amplif
test
separ
target
andor
sequenc
viru
isol
tissu
cultur
serolog
serum
middl
east
respiratori
syndrom
test
collabor
center
establish
test
method
case
confirm
serolog
requir
demonstr
seroconvers
sampl
ideal
taken
least
day
apart
screen
elisa
immunofluoresc
assay
neutral
assay
serolog
test
elisa
merscov
develop
refin
surveil
investig
purpos
indirect
elisa
develop
seroepidemiolog
test
surveil
purpos
requir
evalu
field
studi
merscov
test
must
perform
appropri
equip
biosafeti
laboratori
staff
train
relev
technic
safeti
procedur
nation
guidelin
laboratori
biosafeti
follow
circumst
manag
patient
mer
larg
symptomat
support
aim
reduc
risk
complic
secondari
infect
renal
respiratori
failur
serious
ill
patient
receiv
intens
care
although
rang
exist
development
treatment
may
use
box
current
specif
treatment
treat
merscov
rang
treatment
lopinavirritonavir
pegyl
interferon
ifn
ribavirin
use
empir
seriou
case
mer
accur
evid
base
improv
treatment
outcom
treatment
either
lopinavirritonavir
marmoset
model
associ
improv
clinic
radiolog
patholog
outcom
lower
viral
load
comparison
treatment
wherea
mycophenol
acid
alon
increas
viral
load
fatal
macrolid
therapi
commonli
start
patient
arriv
icu
saudi
arabia
retrospect
studi
patient
mer
found
macrolid
therapi
associ
reduct
mortal
improv
merscov
rna
clearanc
current
ongo
random
control
trial
progress
kingdom
saudi
arabia
compar
lopinavirritonavir
recombin
standard
support
care
placebo
standard
support
care
patient
laboratoryconfirm
mer
requir
hospit
admiss
system
corticosteroid
shown
delay
viral
clearanc
critic
ill
patient
merscov
infect
rang
antimerscov
drug
hostdirect
therapi
consid
potenti
therapi
merscov
properli
design
studi
need
answer
sever
knowledg
gap
us
understand
diseas
pathogenesi
viral
kinet
mode
diseas
transmiss
intermediari
sourc
mer
guid
infect
control
prevent
measur
treatment
respons
merscov
infect
main
infect
prevent
control
measur
manag
patient
mer
well
document
sever
acut
respiratori
syndrom
sar
epidem
earli
identif
isol
suspect
confirm
case
ongo
surveil
key
prevent
nosocomi
spread
droplet
precaut
wear
surgic
mask
within
patient
contact
droplet
precaut
wear
gown
glove
mask
eye
protect
enter
room
remov
leav
must
use
care
patient
suspect
merscov
infect
hcw
implement
airborn
precaut
wear
fittest
particul
respir
eg
us
nation
institut
occup
safeti
healthapprov
filter
facepiec
respir
ffr
european
norm
en
approv
perform
aerosolgener
procedur
infect
potenti
infect
patient
avoid
aerosol
procedur
crowd
hospit
emerg
inpati
medic
ward
adequ
infect
control
measur
place
may
decreas
merscov
humantohuman
spread
environment
contamin
also
prudent
use
higher
level
protect
hcw
extend
close
contact
patient
mer
expos
aerosol
highrisk
procedur
higher
level
ventil
air
chang
higher
air
flow
veloc
greater
effort
prevent
air
dispers
beyond
point
gener
enclosur
use
captur
ventil
higher
level
person
protect
equip
coverag
protect
type
respiratori
protect
necessari
reduc
room
contamin
hospit
set
applic
minimum
room
ventil
rate
air
chang
per
hour
singl
room
least
ls
per
patient
facil
natur
ventil
recommend
care
patient
receiv
mechan
ventil
aerosolgener
procedur
institut
appropri
infect
control
measur
soon
diagnosi
consid
critic
prevent
spread
especi
hospit
symptom
sign
rti
nonspecif
difficult
diagnos
primari
case
patient
merscov
infect
infect
prevent
control
measur
import
prevent
spread
merscov
within
household
commun
health
care
facil
humantohuman
transmiss
occur
within
commun
household
strikingli
within
hospit
set
health
careassoci
outbreak
occur
sever
countri
largest
outbreak
seen
saudi
arabia
uae
republ
korea
sever
outbreak
studi
shown
merscov
appear
transmit
easili
persontoperson
unless
close
contact
provid
clinic
care
merscov
identifi
clinic
specimen
sputum
endotrach
aspir
bronchoalveolar
lavag
nasal
nasopharyng
swab
urin
fece
blood
lung
tissu
mode
merscov
transmiss
direct
indirect
contact
airborn
droplet
ingest
yet
defin
upsurg
number
human
infect
due
merscov
past
year
health
care
facil
middl
east
south
korea
relat
low
awar
merscov
infect
result
nosocomi
outbreak
involv
exist
hospit
patient
outpati
visitor
hcw
within
health
care
facil
overcrowd
lack
isol
room
facil
environment
contamin
inadequ
infect
control
measur
without
signific
chang
transmiss
viru
hcw
alway
undertak
standard
precaut
consist
patient
fever
symptom
rti
droplet
precaut
ad
standard
precaut
provid
care
patient
contact
precaut
eye
protect
includ
care
probabl
confirm
case
merscov
airborn
precaut
import
perform
aerosolgener
procedur
humantohuman
transmiss
commun
live
larg
household
famili
compound
describ
investig
household
contact
index
merscovinfect
saudi
arabian
patient
followup
serolog
analysi
contact
perform
determin
rate
silent
subclin
secondari
infect
exposur
primari
case
merscov
infect
found
probabl
case
secondari
transmiss
confid
interv
sever
report
merscov
carriag
exposur
patient
mer
appar
healthi
household
contact
found
merscov
upper
respiratori
tract
low
level
merscov
rna
detect
asymptomat
hcw
nosocomi
merscov
outbreak
jeddah
hospit
rel
investig
merscov
infect
affect
extend
famili
saudi
arabia
merscov
posit
hospit
die
merscov
endem
countri
merscov
case
occur
commun
household
educ
awar
merscov
mer
prevent
measur
may
reduc
risk
household
transmiss
prevent
commun
cluster
regular
hand
wash
touch
camel
avoid
contact
sick
camel
advis
peopl
avoid
drink
raw
camel
milk
camel
urin
eat
camel
meat
properli
cook
person
diabet
kidney
diseas
chronic
lung
diseas
cancer
immunosuppress
treatment
high
risk
develop
sever
merscov
diseas
thu
avoid
close
contact
camel
bat
advis
special
screen
merscov
point
entri
return
middl
east
current
recommend
applic
travel
trade
restrict
person
histori
travel
arabian
peninsula
within
day
develop
symptom
acut
respiratori
infect
involv
fever
c
cough
radiolog
pulmonari
chang
present
alert
physician
possibl
merscov
infect
vaccin
yet
avail
protect
merscov
infect
sever
group
work
develop
vaccin
use
varieti
platform
shown
efficaci
anim
model
summari
merscov
remain
import
public
health
risk
possibl
consequ
intern
spread
could
seriou
view
pattern
nosocomi
transmiss
within
health
care
facil
million
pilgrim
visit
saudi
arabia
year
countri
perform
hajj
umrah
pilgrimag
watch
surveil
public
health
system
high
degre
clinic
awar
possibl
merscov
infect
essenti
nosocomi
transmiss
often
due
delay
diagnosi
merscov
infect
patient
shed
merscov
crowd
health
care
set
inpati
ward
emerg
depart
renal
dialysi
unit
earli
recognit
case
improv
complianc
intern
recommend
infect
control
protocol
rapid
implement
infect
control
measur
requir
prevent
health
care
facilityassoci
outbreak
merscov
